Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Orano Med LLC
Orano Med LLC
Taiho Oncology, Inc.
Eli Lilly and Company
Prelude Therapeutics
Nuvation Bio Inc.
Quadriga Biosciences, Inc.
Celgene
Tocagen Inc.
AbbVie
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Pharmacyclics LLC.